p 59: non-steroidal anti-inflammatory drugs as a prevention of alzheimer disease: risks and benefits

Authors

ali ebrahimi a. islamic azad university, mashhad branch, mashhad, iran b. members of mashhad neuroscience research group of islamic azad university, mashhad branch, mashhad, iran

anahita ghazaghi a. islamic azad university, mashhad branch, mashhad, iran b. members of mashhad neuroscience research group of islamic azad university, mashhad branch, mashhad, iran

malihe bahadoran a. islamic azad university, mashhad branch, mashhad, iran b. members of mashhad neuroscience research group of islamic azad university, mashhad branch, mashhad, iran

faramarz khojaste a. islamic azad university, mashhad branch, mashhad, iran b. members of mashhad neuroscience research group of islamic azad university, mashhad branch, mashhad, iran

abstract

alzheimer's disease (ad) is a chronic neurodegenerative disease that accounts for 60 to 80 percent of all dementia cases. the exact cause of alzheimer`s disease is still unknown, but recent studies suggest neuro-inflammation as an important part of the pathogenesis of the disease. this brings in mind using non-steroidal anti-inflammatory drugs (nsaid) as treatment or prevention of the disease. in this review, we weigh up some pros and cons of nsaids as alzheimer`s prevention. although we know that most of the trials show effectiveness of long-term nsaid use in prevention of alzheimer's disease, we cannot ignore disadvantages of using them. for example, it is proved that many inflammatory proteins and cytokines have useful and protective functions so we cannot simply suppress them by anti-inflammatory drugs because it may be more harmful than beneficial. even some studies show increased risk of alzheimer's disease in heavy nsaid users. another major disadvantage of nsaids is their side effects such as gastrointestinal and nephrologic complications. using nsaids as prevention of alzheimer`s has been matter of much debate in recent years. we know that still there is no rational explanation for nsaids benefit in alzheimer`s disease, while their harms are quite obvious. based on these facts, nsaids are not yet a recommended medication for the treatment or prevention of alzheimer`s disease.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

P 59: Non-Steroidal Anti-Inflammatory Drugs as a Prevention of Alzheimer Disease: Risks and Benefits

Alzheimer's disease (AD) is a chronic neurodegenerative disease that accounts for 60 to 80 percent of all dementia cases. The exact cause of Alzheimer`s disease is still unknown, but recent studies suggest neuro-inflammation as an important part of the pathogenesis of the disease. This brings in mind using non-steroidal anti-inflammatory drugs (NSAID) as treatment or prevention of the disease. ...

full text

Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks

While aspirin may offer protection, other non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) can cause serious cardiovascular side effects and complications. This has led to a general "black box" warning for cardiovascular adverse events for NSAIDs. This review explores the different mechanisms underlying the protective effects of aspirin, the NSAID associated renovascular effects causi...

full text

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease

Inflammatory Bowel Diseases (IBD) are an immune mediated chronic or relapsing disorders of the gastrointestinal (GI) tract. IBD is characterized by a chronic intestinal inflammatory process with various components contributing to the pathogenesis of the disease including environmental factors such as smoking or use of Non Steroidal Anti-Inflammatory Drugs (NSAIDS). NSAIDS are among the most com...

full text

Non-steroidal anti-inflammatory drugs in cancer prevention and therapy.

Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) can be regarded as an effective approach for cancer chemoprevention, as demonstrated by a bulk of clinical and experimental evidence. However, the clinical use of these drugs as chemopreventive agents is limited by many open questions about the optimal drug, dose, duration of therapy and knowledge about the mechanism(s) by which th...

full text

Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.

Colorectal cancer is the second leading cause of cancer deaths in the United States. Currently, the most effective strategy available for colon cancer prevention is endoscopic screening, with polypectomy or surgical resection for advanced lesions. This intervention carries with it many concerns regarding cost, patient acceptance, and the growing burden of surveillance colonoscopies for patients...

full text

My Resources

Save resource for easier access later


Journal title:
مجله علوم اعصاب شفای خاتم

جلد ۵، شماره ۲، صفحات ۹۰-۹۰

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023